In recent decades, the emphasis of biomarker research has centered around blood-based markers.
Race for universal flu vaccine ramps up as Osivax kicks off Phase IIa trial – Pharmaceutical Technology
3D illustration showing surface glycoprotein spikes of influenza. No universal vaccine for influenza currently exists. Instead, regular vaccines are given that target seasonal strains. Image